Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $19.9300 (-1.82%) ($19.0600 - $21.3900) on Wed. Sep. 27, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.34% (three month average) | RSI | 52 | Latest Price | $19.9300(-1.82%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.4% a day on average for past five trading days. | Weekly Trend | EDIT advances 2.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(63%) IBB(63%) XBI(61%) IWO(58%) ARKK(57%) | Factors Impacting EDIT price | EDIT will decline at least -2.17% in a week (0% probabilities). VIXM(-13%) TLT(-6%) SHY(-5%) UUP(-4%) GDXJ(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.17% (StdDev 4.34%) | Hourly BBV | 0 () | Intraday Trend | -5.1% | | | |
|
Resistance Level | $20.99 | 5 Day Moving Average | $21.47(-7.17%) | 10 Day Moving Average | $21.52(-7.39%) | 20 Day Moving Average | $20.99(-5.05%) | To recent high | -13.9% | To recent low | 29% | Market Cap | $1.238b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |